Article
Evolving or Immutable - Phase I Solid Tumor Trials in the Era of Precision Oncology
2024-04-29
Abstract excerpt
<title>Abstract</title> <p>Purpose In the era of precision oncology (PO), systemic therapies for patients (pts) with solid tumors have shifted from chemotherapy (CT) to targeted therapy (TT) and immunotherapy (IO). This systematic survey describes features of trials enrolling between 2010-2020, focusing on inclusion criteria, type of dose escalation scheme (DES) utilized, and use of expansion cohorts (ECs). Metho...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d2048adf-38a6-522d-a1fc-97b4e5a3ba2c
- DOI
- 10.21203/rs.3.rs-4202155/v1
